Premium
Tumor‐Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti‐FGF23 Monoclonal Antibody
Author(s) -
Whyte Michael P
Publication year - 2021
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.4280
Subject(s) - medicine , osteomalacia , citation , library science , family medicine , vitamin d and neurology , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom